Review by Exception is the ultimate goal of Electronic Batch Records (EBR) and Manufacturing Execution System (MES) implementations at Life-Science organizations. Yet few industry companies have achieved this goal.
Fujirebio Diagnostics Inc. (FDI) is undergoing Digital Transformation, starting with MES / EBR implementation, resulting in a Review by Exception approach for manufacturing batch records.
Join FDI’s Samantha Schloth and Axendia’s Daniel R. Matlis for a live webinar on August 6 at 11:00 AM ET to learn how Digital Transformation is enabling Review by Exception and reducing manufacturing cycle times.
We will discuss:
* Undergoing Digital Transformation.
* Implementation strategy for success
* Moving from Paper to Digital records
* Leveraging FDA’s Risk Based Computer System Assurance Approach
* The Value of Review by Exception
* Lessons learned, challenges and opportunities
Can't make this time? Register and you will be able to watch the On-Demand recording after the event.